generic Eliquis (apixaban)
2.5 mg
True
10605
tablet

Generic Eliquis Prices (apixaban)

Related Drugs: Eliquis

Compare generic Eliquis (apixaban) prices available at international online pharmacies with local U.S. pharmacy coupon prices. The lowest price on PharmacyChecker.com for generic Eliquis (apixaban) 2.5 mg is $0.27 per tablet for 200 tablets at PharmacyChecker-accredited online pharmacies.

Drug Savings Info

Compare generic Eliquis (apixaban) prices available at international online pharmacies with local U.S. pharmacy coupon prices. The lowest price on PharmacyChecker.com for generic Eliquis (apixaban) 2.5 mg is $0.27 per tablet for 200 tablets at PharmacyChecker-accredited online pharmacies.

Viewing Also See
GenericBrand
Viewing Also See
Viewing Also See
InternationalU.S. Coupons
Viewing Also See
You're comparing prices for of apixaban within miles of ZIP Code 10605. Adjust Quantity, Radius, or ZIP Code.

What is Apixaban?

Apixaban (Brand name: Eliquis) is prescribed for the prevention of strokes or blood clots in people who have atrial fibrillation. It also treats and prevents blood clots in the legs and/or lungs. Apixaban works by stopping the action of a natural substance in the body that helps form blood clots. 

In general, the names and strengths of drugs can vary globally due to differing marketing strategies. Any variations need to be approved by your prescriber. In apixaban’s case, the name differs across markets. PharmacyChecker is not aware of strength differences across countries. 

Apixaban is marketed under the brand name Eliquis in much of the world by Pfizer and Bristol-Myers Squibb. 

There are many generic alternatives of Eliquis approved in Canada now. They carry the same active ingredient as Eliquis, apixaban. In Canada, apixaban is approved by Health Canada to be manufactured and marketed by the following companies:

  • Teva Canada Limited marketed under the name Teva-Apixaban 

  • Pro Doc Limitee marketed under the name Pro-Apixaban 

  • Laboratoire Riva Inc marketed under the name Riva Apixaban 

  • Sandoz Canada Incorporated marketed under the name Sandoz Apixaban SDZ 

  • Sun Pharma Canada Inc marketed under the name Taro-Apixaban

  • Marcan Pharmaceuticals Inc marketed under the name Mar-Apixaban 

  • Mint Pharmaceuticals Inc marketed under the name Mint-Apixaban 

  • Natco Pharma (Canada) Inc marketed under the name Nat-Apixaban 

  • Nora Pharma Inc marketed under the name NRA-Apixaban 

  • Auro Pharma Inc marketed under the name Auro-Apixaban 

  • Biomed pharma marketed under the name Bio-apixaban 

  • Bristol Myers Squibb marketed under the name Eliquis 

  • JAMP Pharma Corporation marketed under the name JAMP apixaban 

  • Mantra Pharma Inc marketed under the name M-apixaban 

  • Accord Healthcare Inc marketed under the name ACH-apixaban

  • Angita Pharma Inc. marketed under the name AG-apixaban 

  • Sivem Pharmaceuticals ULC marketed under the name Apixaban 

  • Sanis Health Inc approved under the name Apixaban 

  • Apotex Inc marketed under the name APO-apixaban 

Apixaban is manufactured and marketed under the name Apigat in India by Natco Pharma. In 2019, the Delhi High Court dismissed attempts by Bristol-Myers Squibb to protect its patented apixaban against Natco’s Apigat.

The U.S. FDA has approved the following companies to market a generic version: Indoco, Hetero Labs, Sun Pharma, and Accord, but approval does not equal availability. A generic alternative for Eliquis will most likely be launched in the United States in April 2028. Brand Eliquis is among the first ten medications proposed for Medicare price negotiations in the United States; negotiated pricing would go into effect in 2026.

Apixaban Savings & Safety Information

Apixaban (Brand name: Eliquis) is prescribed for the prevention of strokes or blood clots in people who have atrial fibrillation. It also treats and prevents blood clots in the legs and/or lungs.

Apixaban works by stopping the action of a natural substance in the body that helps form blood clots. 

In general, the names and strengths of drugs can vary globally due to differing marketing strategies. Any variations need to be approved by your prescriber. In apixaban’s case, the name differs across markets. PharmacyChecker is not aware of strength differences across countries. 

Apixaban is marketed under the brand name Eliquis in much of the world by Pfizer and Bristol-Myers Squibb. 

There are many generic alternatives of Eliquis approved in Canada now. They carry the same active ingredient as Eliquis, apixaban. In Canada, apixaban is approved by Health Canada to be manufactured and marketed by the following companies:

  • Teva Canada Limited marketed under the name Teva-Apixaban 

  • Pro Doc Limitee marketed under the name Pro-Apixaban 

  • Laboratoire Riva Inc marketed under the name Riva Apixaban 

  • Sandoz Canada Incorporated marketed under the name Sandoz Apixaban SDZ 

  • Sun Pharma Canada Inc marketed under the name Taro-Apixaban

  • Marcan Pharmaceuticals Inc marketed under the name Mar-Apixaban 

  • Mint Pharmaceuticals Inc marketed under the name Mint-Apixaban 

  • Natco Pharma (Canada) Inc marketed under the name Nat-Apixaban 

  • Nora Pharma Inc marketed under the name NRA-Apixaban 

  • Auro Pharma Inc marketed under the name Auro-Apixaban 

  • Biomed pharma marketed under the name Bio-apixaban 

  • Bristol Myers Squibb marketed under the name Eliquis 

  • JAMP Pharma Corporation marketed under the name JAMP apixaban 

  • Mantra Pharma Inc marketed under the name M-apixaban 

  • Accord Healthcare Inc marketed under the name ACH-apixaban

  • Angita Pharma Inc. marketed under the name AG-apixaban 

  • Sivem Pharmaceuticals ULC marketed under the name Apixaban 

  • Sanis Health Inc approved under the name Apixaban 

  • Apotex Inc marketed under the name APO-apixaban 

Apixaban is manufactured and marketed under the name Apigat in India by Natco Pharma. In 2019, the Delhi High Court dismissed attempts by Bristol-Myers Squibb to protect its patented apixaban against Natco’s Apigat.

The U.S. FDA has approved the following companies to market a generic version: Indoco, Hetero Labs, Sun Pharma, and Accord, but approval does not equal availability. A generic alternative for Eliquis will most likely be launched in the United States in April 2028. Brand Eliquis is among the first ten medications proposed for Medicare price negotiations in the United States; negotiated pricing would go into effect in 2026.

Read More

The total price includes shipping fees which typically cover an entire order, making it more economical to purchase multiple medications in the same order.

U.S. government officials have stated that individuals who order non-controlled prescription drugs from Canada or other foreign sources (up to a three-month supply) for their own use are not being pursued or prosecuted - although it is technically not legal for individuals to import most prescription drugs. The U.S FDA regulates the safety and efficacy of medications sold in U.S. pharmacies. Medications dispensed from outside the U.S. are regulated for safety and efficacy by pharmaceutical/pharmacy regulatory authorities in other countries. Read how regulations may differ by country.

Enter your ZIP Code and Prescribed Quantity

Select Quantity

Select Radius

ZIP Code

The icon means that this online pharmacy only ships from dispensing pharmacies located in Canada. Separately, the Tier 1 icon means that an online pharmacy accredited by PharmacyChecker only fills prescription orders through their own pharmacy or dispensing pharmacy partners in Australia, Canada, Israel, New Zealand, United Kingdom, or the U.S. Such countries are known to have equally advanced pharmaceutical and pharmacy regulatory systems. Please note that all PharmacyChecker-accredited online pharmacies (tier 1 and non-tier 1) meet the same high standards as identified in the PharmacyChecker Verification Program.

For more about Tier 1 international pharmacies click here.

The Tier 1 icon means that an online pharmacy accredited by PharmacyChecker only fills prescription orders through their own pharmacy or dispensing pharmacy partners in Australia, Canada, Israel, New Zealand, United Kingdom, or the U.S. Such countries are known to have equally advanced pharmaceutical and pharmacy regulatory systems. Please note that all PharmacyChecker-accredited online pharmacies (tier 1 and non-tier 1) meet the same high standards as identified in the PharmacyChecker Verification Program.

For more about Tier 1 international pharmacies click here.

The icon means that this online pharmacy accredited by PharmacyChecker fills prescription orders through either their own pharmacy or dispensing pharmacy partners located in Australia, India, Mauritius, New Zealand, Turkey, the UK, or Canada. Please note that all PharmacyChecker-accredited online pharmacies (tier 1 and non-tier 1) meet the same high standards as identified in the PharmacyChecker Verification Program.

For information about Tier 1 international pharmacies click here.

PharmacyChecker uses cookies to track & improve your online experience.